4/A//SEC Filing
Javitt Jonathan C 4/A
Accession 0000921895-22-001874
CIK 0001719406other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 9:46 AM ET
Size
6.7 KB
Accession
0000921895-22-001874
Insider Transaction Report
Form 4/AAmended
Javitt Jonathan C
DirectorChairman and Chief Scientist10% Owner
Transactions
- Purchase
Common Stock
2022-06-01$0.58/sh+100,000$58,000→ 146,332 total
Holdings
- 1,422,000(indirect: By Trust)
Common Stock
- 13,299,997(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Reflects charitable donations of 49,000 shares of Common Stock that occurred in December 2021.
- [F2]Held by the Jonathan Javitt Living Trust of which the Reporting Person is trustee.
- [F3]Held by The Javitt 2012 Irrevocable Dynasty Trust of which the Reporting Person is the Grantor.
Documents
Issuer
NRX Pharmaceuticals, Inc.
CIK 0001719406
Entity typeother
Related Parties
1- filerCIK 0001303782
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 9:46 AM ET
- Size
- 6.7 KB